EN
HI
Summary
As of 14 Nov, 2026, Aspira Pathlab & Diagnostics stock price is ₹123. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Aspira Pathlab & Diagnostics has traded between ₹49.00 and ₹135.88.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹123.00.
Aspira Pathlab & Diagnostics has an upper circuit limit of ₹129.15 and a lower circuit limit of ₹116.85. The total value traded stands at ₹0.00, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Aspira Pathlab & Diagnostics also offers a dividend yield of 0%.
Aspira Pathlab & Diagnostics Share Price Chart
Aspira Pathlab & Diagnostics Share Key Metrics
Volume
0.00
Market Cap
99.84 CR
LTQ@LTP
0@123.00
ATP
0
Var Margin
28.69 %
Circuit Range
116.85-129.15
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
1
Aspira Pathlab & Diagnostics Fundamentals
P/E Ratio
52.77
P/B Ratio
10.02
Div. Yield
0
Sector P/E
57.06
Sector P/B
-13.37
Sec. Div. Yield
0.18
Aspira Pathlab & Diagnostics Resistance and Support
Pivot 121.37
Resistance
First Resistance
128.09
Second Resistance
133.17
Third Resistance
139.89
Support
First Support
116.29
Second Support
109.57
Third Support
104.49
Aspira Pathlab & Diagnostics Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 116.9 | 129.15 | 5.00% | 129.15 | 116.9 |
| Thu Nov 12 2026 | 116.05 | 123 | 1.95% | 126.44 | 114.65 |
| Wed Nov 11 2026 | 126.34 | 120.65 | -4.96% | 131 | 120.65 |
Aspira Pathlab & Diagnostics Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-06 | Quarterly Results |
| 2026-09-12 | Others |
| 2026-08-12 | Quarterly Results & Raising of funds |
| 2026-05-23 | Audited Results |
| 2026-02-10 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-02-07 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Aspira Pathlab & Diagnostics News
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome for Outcome Of Board Meeting Dated 6Th November 2026
Aspira Pathlab reported Q2 FY27 revenue of ₹6.26 crore, down 22.6% YoY, with a net loss of ₹1.16 crore against a profit of ₹1.84 crore last year. The company also disclosed unresolved legal claims amounting to ₹1.11 crore regarding the premature termination of lease arrangements.
Nov 06 2026 16:22:45
Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Board Meeting To Be Held On November 06, 2026 For The Second Quarter/Half Year Ended September 30, 2026
Aspira Pathlab board will meet on 06 Nov 2026 to consider financial results.
Oct 31 2026 12:31:19
Aspira Pathlab & Diagnostics Management
| Name | Position |
|---|---|
| Haseeb A Drabu | Chairman |
| Pankaj Shah | Managing Director & Chief Executive Officer |
Aspira Pathlab & Diagnostics Similar Stocks
Bal Pharma Ltd.
88.23
0.00 (0.00%)
Parnax Lab Ltd.
108.35
0.00 (0.00%)
Raaj Medisafe India Ltd.
100.00
-2.00 (1.96%)
Star Imaging and Path Lab Ltd.
68.12
0.00 (0.00%)
Alpa Laboratories Ltd.
55.56
0.00 (0.00%)
Mercury Laboratories Ltd.
750.40
0.00 (0.00%)
Bharat Immunologicals & Biologicals Corporation Ltd.
9.02
0.00 (0.00%)
Aspira Pathlab & Diagnostics FAQs
The Buying Price of Aspira Pathlab & Diagnostics share is 123 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 52.77. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 10.02. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 57.06 & -13.37 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 99.84 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 135.88 & 49.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aspira Pathlab & Diagnostics belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ASPIRA
